We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
(+11%)
Cap. Flow
+$3.18B
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.93B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Cencora
COR
|
+$492M |
| 4 |
Netflix
NFLX
|
+$452M |
| 5 |
Bank of America
BAC
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$636M |
| 2 |
Eli Lilly
LLY
|
+$572M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$502M |
| 4 |
Advanced Micro Devices
AMD
|
+$395M |
| 5 |
CRH
CRH
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.19% |
| 2 | Consumer Discretionary | 12.64% |
| 3 | Healthcare | 9.35% |
| 4 | Financials | 8.34% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTT
2376
High Templar Tech Ltd
HTT
$370M
| $320K | ﹤0.01% |
75,043
-107,071
| -59% | -$429K |
|
2377
Amprius Technologies
AMPX
$1.2B
| $319K | ﹤0.01% |
30,368
-1,075,045
| -97% | -$8.46M |
|
2378
Idexx Laboratories
IDXX
$44.9B
| $319K | ﹤0.01% |
500
-19,500
| -98% | -$11.8M |
|
2379
Viemed Healthcare
VMD
$447M
| $319K | ﹤0.01% |
46,994
+25,715
| +121% | +$174K |
|
2380
Greenwich LifeSciences
GLSI
$188M
| $319K | ﹤0.01% |
32,051
-24,091
| -43% | -$272K |
|
|
HOUS
2381
DELISTED
Anywhere Real Estate
HOUS
| $319K | ﹤0.01% |
+30,100
| New | +$177K |
|
2382
PUT
Invesco CurrencyShares Japanese Yen Trust
FXY
$427M
| $317K | ﹤0.01% |
5,100
| – | – |
|
2383
Electromed
ELMD
$333M
| $317K | ﹤0.01% |
+12,922
| New | +$274K |
|
2384
Corpay
CPAY
$25.7B
| $317K | ﹤0.01% |
1,100
-500
| -31% | -$159K |
|
2385
Liberty Latin America Class C
LILAK
$1.69B
| $314K | ﹤0.01% |
+40,977
| New | +$280K |
|
|
SVCO
2386
Silvaco Group
SVCO
$232M
| $314K | ﹤0.01% |
58,082
+24,813
| +75% | +$121K |
|
2387
CALL
Vertex Pharmaceuticals
VRTX
$123B
| $313K | ﹤0.01% |
+800
| New | +$334K |
|
2388
New Mountain Finance
NMFC
$654M
| $311K | ﹤0.01% |
32,273
-185,990
| -85% | -$1.93M |
|
2389
Gain Therapeutics
GANX
$72.1M
| $310K | ﹤0.01% |
175,107
-101,326
| -37% | -$171K |
|
2390
CALL
McKesson
MCK
$104B
| $309K | ﹤0.01% |
+400
| New | +$282K |
|
2391
Star Holdings Shares of Beneficial Interest
STHO
$112M
| $309K | ﹤0.01% |
+37,542
| New | +$305K |
|
2392
Vuzix
VUZI
$178M
| $309K | ﹤0.01% |
98,602
-1,050,505
| -91% | -$2.48M |
|
2393
NN Inc
NNBR
$237M
| $308K | ﹤0.01% |
149,682
-107,552
| -42% | -$241K |
|
2394
CALL
Biogen
BIIB
$30.9B
| $308K | ﹤0.01% |
+2,200
| New | +$297K |
|
2395
Claros Mortgage Trust
CMTG
$290M
| $308K | ﹤0.01% |
92,722
+11,057
| +14% | +$37.2K |
|
2396
Meritage Homes
MTH
$4.78B
| $308K | ﹤0.01% |
4,246
-376,016
| -99% | -$27.9M |
|
|
JHG
2397
DELISTED
Janus Henderson
JHG
| $307K | ﹤0.01% |
6,890
-16,468
| -71% | -$711K |
|
2398
Daktronics
DAKT
$946M
| $305K | ﹤0.01% |
+14,578
| New | +$262K |
|
2399
ICU Medical
ICUI
$4.16B
| $305K | ﹤0.01% |
+2,540
| New | +$322K |
|
2400
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $305K | ﹤0.01% |
6,700
-12,435
| -65% | -$588K |
|
Similar funds
Marshall Wace's Q3 2025 Portfolio in Review
As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.
- Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
- Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
- Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
- Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
- Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.
Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.